Please use this identifier to cite or link to this item:
https://hdl.handle.net/11147/10072| Title: | A Study of Multiple Drug Resistance Mechanisms Improved Against Bortezomib on Multiple Myeloma Cell Lines in Vitro | Authors: | Uyuklu, Tolga Ural, A. Uğur Sarper, Metal Avcu, Ferit Baran, Yusuf Elçi, Pınar Akar, Nejat |
Publisher: | American Society of Hematology | Abstract: | The most important problem in the treatment of Multiple Myeloma (MM) is the multi drug resistance (MDR) observed before and after the treatment. For this reason in MM cases an early resistance to treatment can be developed or the disease can relapsed in early period. Yet, there has been no improved drug resistance against proteazom inhibitor Bortezomib (Bor), which is used alone or with other chemotherapeutic agents in resistant or relapsed MM cases | Description: | 49th Annual Meeting of the American-Society-of-Hematology | URI: | https://doi.org/10.1182/blood.V110.11.4183.4183 https://hdl.handle.net/11147/10072 |
ISSN: | 0006-4971 1528-0020 |
| Appears in Collections: | Molecular Biology and Genetics / Moleküler Biyoloji ve Genetik WoS İndeksli Yayınlar Koleksiyonu / WoS Indexed Publications Collection |
Files in This Item:
| File | Size | Format | |
|---|---|---|---|
| 1-s2.0-S0006497118404351-main.pdf | 62.24 kB | Adobe PDF | View/Open |
CORE Recommender
Items in GCRIS Repository are protected by copyright, with all rights reserved, unless otherwise indicated.